Authors:
FINBERG JPM
TAKESHIMA T
JOHNSTON JM
COMMISSIONG JW
Citation: Jpm. Finberg et al., INCREASED SURVIVAL OF DOPAMINERGIC-NEURONS BY RASAGILINE, A MONOAMINE-OXIDASE-B INHIBITOR, NeuroReport, 9(4), 1998, pp. 703-707
Authors:
FINBERG JPM
WANG J
BANKIEWICZ K
HARVEYWHITE J
KOPIN IJ
GOLDSTEIN DS
Citation: Jpm. Finberg et al., INCREASED STRIATAL DOPAMINE PRODUCTION FROM L-DOPA FOLLOWING SELECTIVE-INHIBITION OF MONOAMINE-OXIDASE-B BY R(-N-PROPARGYL-1-AMINOINDAN (RASAGILINE) IN THE MONKEY()), Journal of neural transmission. Supplementum, (52), 1998, pp. 279-285
Citation: I. Lamensdorf et Jpm. Finberg, REDUCED STRIATAL TYROSINE-HYDROXYLASE ACTIVITY IS NOT ACCOMPANIED BY CHANGE IN RESPONSIVENESS OF DOPAMINERGIC RECEPTORS FOLLOWING CHRONIC TREATMENT WITH DEPRENYL, Neuropharmacology, 36(10), 1997, pp. 1455-1461
Citation: D. Benshachar et al., EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF FLUVOXAMINE ON NORADRENALINE RELEASE IN RAT-BRAIN, European journal of pharmacology, 332(3), 1997, pp. 237-243
Citation: Jpm. Finberg et al., MICRODIALYSIS STUDY OF THE MODIFICATION OF STRIATAL DOPAMINE RELEASE BY CHRONIC TREATMENT WITH SELECTIVE INHIBITORS OF MAO-A AND MAO-B IN THE GUINEA-PIG, British Journal of Pharmacology, 122, 1997, pp. 43-43
Authors:
FINBERG JPM
LAMENSDORF I
COMMISSIONG JW
YOUDIM MBH
Citation: Jpm. Finberg et al., PHARMACOLOGY AND NEUROPROTECTIVE PROPERTIES OF RASAGILINE, Journal of neural transmission. Supplementum, (48), 1996, pp. 95-101
Citation: I. Lamensdorf et al., EFFECT OF LONG-TERM TREATMENT WITH SELECTIVE MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B INHIBITORS ON DOPAMINE RELEASE FROM RAT STRIATUM IN-VIVO, Journal of neurochemistry, 67(4), 1996, pp. 1532-1539
Authors:
FINBERG JPM
LAMENSDORF I
WANG J
BANKIEWICZ KS
GOLDSTEIN DS
KOPIN IJ
YOUDIM MBH
Citation: Jpm. Finberg et al., STRIATAL DOPAMINE RELEASE FOLLOWING ACUTE OR CHRONIC SELECTIVE-INHIBITION OF MONOAMINE OXIDASE-B TVP-1012 AND DEPRENYL, Annals of neurology, 38(2), 1995, pp. 316-316
Authors:
YOUDIM MBH
MELAMED E
RECHES A
TATTON W
COMMISSIONG J
LAVY R
FINBERG JPM
Citation: Mbh. Youdim et al., NEUROPROTECTIVE AND NEURORESCUE ACTIVITIES OF RASAGILINE (TVP 1012,N-PROPARGYL-1 [R]-AMINO-INDAN), Annals of neurology, 38(2), 1995, pp. 317-317
Authors:
FINBERG JPM
WANG J
GOLDSTEIN DS
KOPIN IJ
BANKIEWICZ KS
Citation: Jpm. Finberg et al., INFLUENCE OF SELECTIVE-INHIBITION OF MONOAMINE-OXIDASE-A OR MONOAMINE-OXIDASE-B ON STRIATAL METABOLISM OF L-DOPA IN HEMIPARKINSONIAN RATS, Journal of neurochemistry, 65(3), 1995, pp. 1213-1220
Citation: Jpm. Finberg, PHARMACOLOGY OF REVERSIBLE AND SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE TYPE-A, Acta psychiatrica Scandinavica, 91, 1995, pp. 8-13
Citation: G. Lavian et al., COMPARISON OF THE EFFECT OF REVERSIBLE AND IRREVERSIBLE MAO INHIBITORS ON RENAL NERVE ACTIVITY IN THE ANESTHETIZED RAT, Journal of neural transmission. Supplementum, (41), 1994, pp. 107-113
Authors:
FINBERG JPM
PACAK K
GOLDSTEIN DS
KOPIN IJ
Citation: Jpm. Finberg et al., MODIFICATION OF CEREBRAL CORTICAL NORADRENALINE RELEASE BY CHRONIC INHIBITION OF MAO-A, Journal of neural transmission. Supplementum, (41), 1994, pp. 123-125
Citation: G. Eisenhofer et Jpm. Finberg, DIFFERENT METABOLISM OF NOREPINEPHRINE AND EPINEPHRINE BY CATECHOL-O-METHYLTRANSFERASE AND MONOAMINE-OXIDASE IN RATS, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1242-1251
Citation: Mbh. Youdim et Jpm. Finberg, PHARMACOLOGICAL ACTIONS OF L-DEPRENYL (SELEGILINE) AND OTHER SELECTIVE MONOAMINE-OXIDASE-B INHIBITOR, Clinical pharmacology and therapeutics, 56(6), 1994, pp. 725-733
Citation: Jpm. Finberg et al., VASCULAR EFFECTS OF ENDOTHELIN IN RAT CORPUS CAVERNOSUM, British Journal of Pharmacology, 112, 1994, pp. 210000083-210000083
Authors:
TANNE Z
COLEMAN R
NAHIR M
SHOMRAT D
FINBERG JPM
YOUDIM MBH
Citation: Z. Tanne et al., ULTRASTRUCTURAL AND CYTOCHEMICAL CHANGES IN THE HEART OF IRON-DEFICIENT RATS, Biochemical pharmacology, 47(10), 1994, pp. 1759-1766
Citation: G. Lavian et al., THE ADVENT OF A NEW-GENERATION OF MONOAMINE-OXIDASE INHIBITOR ANTIDEPRESSANTS - PHARMACOLOGICAL STUDIES WITH MOCLOBEMIDE AND BROFAROMINE, Clinical neuropharmacology, 16, 1993, pp. 190000001-190000007
Authors:
FINBERG JPM
PACAK K
KOPIN IJ
GOLDSTEIN DS
Citation: Jpm. Finberg et al., CHRONIC INHIBITION OF MONOAMINE-OXIDASE TYPE-A INCREASES NORADRENALINE RELEASE IN RAT FRONTAL-CORTEX, Naunyn-Schmiedeberg's archives of pharmacology, 347(5), 1993, pp. 500-505